BBIO

ASND BBIO Biotechnology BMRN ONeil Trader Uncategorized

Ascendis Pharma: Yuviwel Approved Despite Legal Challenges

Mar 3, 2026

AZN BBIO BIIB Biotechnology Bret Jensen GSK IONS NTLA NVS PFE REGN Uncategorized

Ionis Pharmaceuticals: Digesting Recent Events

Feb 27, 2026

APLS BBIO Biotechnology BMRN CRSP NTLA RARE RGNX Uncategorized

Rare disease pharmas could benefit from FDA guidance to accelerate development

Feb 23, 2026

bridgebio-pharma-prices-$550m-convertible-bond-offering

BBIO Biotechnology Uncategorized

BridgeBio Pharma prices $550M convertible bond offering

Jan 16, 2026

Comments BridgeBio Pharma (BBIO) has priced its private offering of $550M aggregate principal amount of...

bridgebio-plans-$550m-convertible-notes-offering-due-2033

BBIO Biotechnology Uncategorized

BridgeBio plans $550M convertible notes offering due 2033

Jan 14, 2026

Comments BridgeBio Pharma (BBIO) on Wednesday said it plans to offer $550 million of convertible...

abivax-is-the-top-performing-biotechnology-stock-ytd

ABVX ARWR BBIO Biotechnology CDTX CELC COGT FHLC FXH GRAL IHI IXJ IYH MLYS OLMA PRAX Uncategorized VHT XLV

Abivax is the top performing biotechnology stock YTD

Dec 22, 2025

Comments Eoneren/E+ via Getty Images The S&P healthcare index (XLV) saw moderate gains in 2025,...